Ze-Fei Jiang

13.3k citations
192 papers · 10.1k · 5 hit papers · h-index 39

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Breast Cancer Treatment Studies 68
    • Cancer Genomics and Diagnostics 10
    • HER2/EGFR in Cancer Research 49
    • Cancer Treatment and Pharmacology 18
    • Bone health and treatments 8
    • Cancer Immunotherapy and Biomarkers 7
    • Cancer Cells and Metastasis 7

Ze-Fei Jiang

183 papers receiving 9.9k citations

Ze-Fei Jiang's Hit Papers

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial 2024 · 97 citations
970+4+8Years since publication5001k1.5k2k2.5k

Peers

Ze-Fei Jiang
Comparison fields: 5 of 121
  • Cancer Research 4k
  • Oncology 2.9k
  • Pulmonary and Respiratory Medicine 1.3k
  • Health Informatics 66
  • Radiology, Nuclear Medicine and Imaging 543
Replace Tiffany A. Traina with:
Tiffany A. Traina United States
Zhi‐Ming Shao China
Gideon Michael Blumenthal United States
Vandana Gupta Abramson United States
Melinda L. Telli United States
Ulrike Anneliese Nitz Germany
Barbara A. Conley United States
Shenghui W. Tang United States
Theodoros Foukakis Sweden
Joseph Geradts United States
Ze-Fei Jiang relative to Tiffany A. Traina United States Tiffany A. Traina's profile →
Citations per field
00.5×1.7×
Tiffany A. Traina · 1×
Citations per year

Countries citing papers authored by Ze-Fei Jiang

Since Specialization
Citations

This map shows the geographic impact of Ze-Fei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze-Fei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze-Fei Jiang more than expected).

Fields of papers citing papers by Ze-Fei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze-Fei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze-Fei Jiang. The network helps show where Ze-Fei Jiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Ze-Fei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ze-Fei Jiang Line = papers co-authored together Ze-Fei Jiang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Hit paper breakdown →
20132987
2
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
Hit paper breakdown →
2017918
3 2017469
4
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2017460
5 2010436
6 2019276
7
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Hit paper breakdown →
2021275
8 2015258
9 2021238
10 2014231
11 2019224
12 2019153
13 2020143
14 2013128
15 2019127
16
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
Hit paper breakdown →
202497
17 201395
18 200588
19 202087
20 200773

About Ze-Fei Jiang

Ze-Fei Jiang is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Health Informatics and Pathology and Forensic Medicine, having authored 192 papers that have together received 10.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (68 papers), HER2/EGFR in Cancer Research (49 papers), Advanced Breast Cancer Therapies (25 papers), Cancer Treatment and Pharmacology (18 papers), Cancer Genomics and Diagnostics (10 papers), Bone health and treatments (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Cancer Research (4k citations), Oncology (2.9k citations), Pulmonary and Respiratory Medicine (1.3k citations), Health Informatics (66 citations) and Radiology, Nuclear Medicine and Imaging (543 citations). Ze-Fei Jiang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shaohua Zhang, Jianbin Li, Zhongsheng Tong, Qingyuan Zhang, Binghe Xu, Santai Song, Li Bian, Xiaojia Wang, Jifeng Feng and Shusen Wang. Their work appears in journals such as Annals of Oncology, Annals of Translational Medicine, Frontiers in Oncology, The Lancet Oncology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact